Cargando…
Low-dose vs. standard-dose intravenous alteplase for acute ischemic stroke with unknown time of onset
BACKGROUND: Standard-dose intravenous alteplase for acute ischemic stroke (AIS) in the unknown or extended time window beyond 4.5 h after symptom onset is both effective and safe for certain patients who were selected based on multimodal neuroimaging. However, uncertainty exists regarding the potent...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175638/ https://www.ncbi.nlm.nih.gov/pubmed/37188314 http://dx.doi.org/10.3389/fneur.2023.1165237 |